EGFR and renal cell carcinoma: In the analysis of the distribution of key copy number alterations in the 78 genes found to be characteristic of the four “TMB/CNA” subgroups, the main findings revealed that EGFR amplification was the most frequent alteration and was more prevalent in bladder cancer, followed by RCC.